Biogen (BIIB) Hmangaihna Thlan
Thlanh chiah a ngai$227.93Updated 25 Sep 2026 19:59 UTC
Change+0.69%
AI forecast: BIIB
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Lai a ngaih a hnu a 6 thlang
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Ri hlaam thlan a nih hi
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumHmi hnuai thawn
Biogen Inc. develops, manufactures, and commercializes therapies with a focus on neurology, oncology, and immunology. The company’s products are designed to treat conditions such as multiple sclerosis, non-Hodgkin lymphoma, rheumatoid arthritis, Crohn’s disease, and psoriasis.
